Barry Jacobson to Male
This is a "connection" page, showing publications Barry Jacobson has written about Male.
Connection Strength
0,587
-
Early Online. S Afr Med J. 2024 Jul 19; 114(7):e2109.
Score: 0,102
-
Baseline characteristics of 32 patients with Gaucher disease who were treated with imiglucerase: South African data from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. S Afr Med J. 2022 02 02; 112(1):13518.
Score: 0,086
-
Conservative Management of Overanticoagulation in Patients With Low-Moderate Risk for Bleeding Complications. Clin Appl Thromb Hemost. 2018 Nov; 24(8):1255-1260.
Score: 0,067
-
The impact of risk assessment on the implementation of venous thromboembolism prophylaxis in foot and ankle surgery. Foot Ankle Surg. 2014 Jun; 20(2):85-9.
Score: 0,049
-
The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals. Thromb Haemost. 2010 Dec; 104(6):1228-34.
Score: 0,039
-
Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AF. Open Heart. 2024 Jul 01; 11(2).
Score: 0,026
-
The BEST study--a prospective study to compare business class versus economy class air travel as a cause of thrombosis. S Afr Med J. 2003 Jul; 93(7):522-8.
Score: 0,024
-
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial. Lancet Haematol. 2022 Aug; 9(8):e594-e604.
Score: 0,022
-
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. PLoS Med. 2022 06; 19(6):e1004024.
Score: 0,022
-
Risk factors for deep vein thrombosis in short-haul cockpit crews: a prospective study. Aviat Space Environ Med. 2002 May; 73(5):481-4.
Score: 0,022
-
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet. 2022 03 19; 399(10330):1141-1153.
Score: 0,022
-
Stable warfarin dose prediction in sub-Saharan African patients: A machine-learning approach and external validation of a clinical dose-initiation algorithm. CPT Pharmacometrics Syst Pharmacol. 2022 01; 11(1):20-29.
Score: 0,021
-
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. Am Heart J. 2019 07; 213:35-46.
Score: 0,018
-
Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa. PLoS One. 2018; 13(10):e0204899.
Score: 0,017
-
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry. PLoS One. 2016; 11(10):e0164076.
Score: 0,015
-
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 04 05; 366(14):1287-97.
Score: 0,011
-
Aspirin resistance in South African Caucasian patients with thrombotic cerebrovascular events. J Neurol Sci. 2009 Feb 15; 277(1-2):80-2.
Score: 0,009
-
Human immunodeficiency virus infection and acute deep vein thromboses. Clin Appl Thromb Hemost. 2008 Jul; 14(3):352-5.
Score: 0,008
-
Erythrocyte sedimentation rate as a marker of inflammation and ongoing coagulation in stroke and transient ischaemic attack. S Afr Med J. 2005 Aug; 95(8):607-12.
Score: 0,007